This workshop will be conducted in Japanese Language only.
Online Registration has been closed. Onsite Registration will be available at Nihonbashi Life Science Building.
Asami Ezaki, MS Division of Strategic Planning and Evaluation & Office of Drug Discovery Support
Japan Agency for Medical Research and Development, Japan
Yasuhiro Honsho Associate Director, Safety & Risk Management Department
Daiichi Sankyo Co., Ltd., Japan
Yuji Ito Prescribing Information Group, RA Functions Dept., Regulatory Affairs Japan
Novartis Pharma K.K., Japan
Kana Maruyama Manager, Regulatory Affairs Unit
Viatris Inc., Japan
Ken Nakajima, RPh Quality Assurance Division Safety Management Department
Otsuka Pharmaceutical Factory, Inc, Japan
Yuji Ohne Senior Director of Regulatory Compliance
Aurion Biotech Japan, Japan
Keinosuke Okazaki Pharmacovigilance, Safety-1
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Mikiko Shitara Senior Manager, Regulatory Affairs Dept.
Alexionpharma GK, Japan
Rie Matsui, RPh Senior Director, International Labeling APAC
Pfizer R&D Japan G.K., Japan
Akiyoshi Uchiyama President
Artage Inc., Japan
Have an account?